LncRNA CARMN suppresses EMT through inhibiting transcription of MMP2 activated by DHX9 in breast cancer

Sung, 2021, Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J. Clin., 71, 209, 10.3322/caac.21660 Sung, 2021, Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J. Clin., 71, 209, 10.3322/caac.21660 Loibl, 2021, Breast cancer, Lancet Lond. Engl., 397, 1750, 10.1016/S0140-6736(20)32381-3 Sakai, 2016, TP53 mutation at early stage of colorectal cancer progression from two types of laterally spreading tumors, Cancer Sci., 107, 820, 10.1111/cas.12930 Kadota, 2016, KRAS mutation is a significant prognostic factor in early-stage lung adenocarcinoma, Am. J. Surg. Pathol., 40, 1579, 10.1097/PAS.0000000000000744 Devis, 2017, Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early-stage endometrioid endometrial cancer, J. Pathol., 241, 475, 10.1002/path.4851 Mercer, 2009, Long non-coding RNAs: insights into functions, Nat. Rev. Genet., 10, 155, 10.1038/nrg2521 Bhan, 2017, Long noncoding RNA and Cancer: a new paradigm, Cancer Res., 77, 3965, 10.1158/0008-5472.CAN-16-2634 Ounzain, 2015, CARMEN, a human super enhancer-associated long noncoding RNA controlling cardiac specification, differentiation and homeostasis, J. Mol. Cell. Cardiol., 89, 98, 10.1016/j.yjmcc.2015.09.016 Shi, 2019, LncRNA miR143HG up-regulates p53 in endometrial carcinoma by sponging miR-125a, Cancer Manag. Res., 11, 10117, 10.2147/CMAR.S222215 Xie, 2019, LncRNA miR143HG suppresses bladder cancer development through inactivating Wnt/β-catenin pathway by modulating miR-1275/AXIN2 axis, J. Cell. Physiol., 234, 11156, 10.1002/jcp.27764 Xun, 2020, LncRNA miR143HG suppresses miR-21 through methylation to inhibit cell invasion and migration, Laryngoscope, 130, E640, 10.1002/lary.28474 Lin, 2019, Long non-coding RNA miR143HG predicts good prognosis and inhibits tumor multiplication and metastasis by suppressing mitogen-activated protein kinase and Wnt signaling pathways in hepatocellular carcinoma, Hepatol. Res. Off. J. Jpn. Soc. Hepatol., 49, 902, 10.1111/hepr.13344 Xu, 2020, Single-cell profiling of long noncoding RNAs and their cell lineage commitment roles via RNA-DNA-DNA triplex formation in mammary epithelium, Stem Cells Dayt. Ohio., 10.1002/stem.3274 Sheng, 2021, LncRNA CARMN overexpression promotes prognosis and chemosensitivity of triple negative breast cancer via acting as miR143-3p host gene and inhibiting DNA replication, J. Exp. Clin. Cancer Res. CR, 40, 205, 10.1186/s13046-021-02015-4 Zhang, 2019, Integrative transcriptome data mining for identification of core lncRNAs in breast cancer, PeerJ, 7, 10.7717/peerj.7821 Zhang, 2016, Long non-coding RNA chromogenic in situ hybridisation signal pattern correlation with breast tumour pathology, J. Clin. Pathol., 69, 76, 10.1136/jclinpath-2015-203275 Abba, 2015, A molecular portrait of high-grade ductal carcinoma in situ, Cancer Res., 75, 3980, 10.1158/0008-5472.CAN-15-0506 Köhrmann, 2009, Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: new findings and review of the literature, BMC Cancer, 9, 188, 10.1186/1471-2407-9-188 Hnisz, 2013, Super-enhancers in the control of cell identity and disease, Cell, 155, 934, 10.1016/j.cell.2013.09.053 Wang, 2011, Molecular mechanisms of long noncoding RNAs, Mol. Cell, 43, 904, 10.1016/j.molcel.2011.08.018 Pellizzoni, 2001, A functional interaction between the survival motor neuron complex and RNA polymerase II, J. Cell Biol., 152, 75, 10.1083/jcb.152.1.75 Myöhänen, 2001, Sequence-specific DNA binding activity of RNA helicase a to the p16INK4a promoter, J. Biol. Chem., 276, 1634, 10.1074/jbc.M004481200 Venkatesh, 2021, LncRNA-miRNA axes in breast cancer: novel points of interaction for strategic attack, Cancer Lett., 509, 81, 10.1016/j.canlet.2021.04.002 Gerdes, 2018, Single cell heterogeneity in ductal carcinoma in situ of breast, Mod. Pathol. Off. J. U. S. Can. Acad. Pathol. Inc., 31, 406 Shay, 2015, Moving targets: emerging roles for MMPs in cancer progression and metastasis, Matrix Biol. J. Int. Soc Matrix Biol., 44–46, 200, 10.1016/j.matbio.2015.01.019 Minn, 2005, Genes that mediate breast cancer metastasis to lung, Nature, 436, 518, 10.1038/nature03799 Gupta, 2007, Mediators of vascular remodelling co-opted for sequential steps in lung metastasis, Nature, 446, 765, 10.1038/nature05760 Ribeiro, 2010, Extracellular cleavage and shedding of P-cadherin: a mechanism underlying the invasive behaviour of breast cancer cells, Oncogene, 29, 392, 10.1038/onc.2009.338 Yan, 2019, Circular RNA circPICALM sponges miR-1265 to inhibit bladder cancer metastasis and influence FAK phosphorylation, EBioMedicine, 48, 316, 10.1016/j.ebiom.2019.08.074 Yan, 2019, DHX9 inhibits epithelial-mesenchymal transition in human lung adenocarcinoma cells by regulating STAT3, Am. J. Transl. Res., 11, 4881 Schlegel, 2003, Overexpression of a protein fragment of RNA helicase a causes inhibition of endogenous BRCA1 function and defects in ploidy and cytokinesis in mammary epithelial cells, Oncogene, 22, 983, 10.1038/sj.onc.1206195 Huo, 2010, RNA helicase a is a DNA-binding partner for EGFR-mediated transcriptional activation in the nucleus, Proc. Natl. Acad. Sci. U. S. A., 107, 16125, 10.1073/pnas.1000743107 Turanli, 2019, Multi-Omic data interpretation to repurpose subtype specific drug candidates for breast Cancer, Front. Genet., 10, 420, 10.3389/fgene.2019.00420